NIH-funded research Sbir 1 grant

Developing a device to accurately detect recent cannabis use from saliva

Official title: Advancement of a Point-of-Need (PoN) platform device for accurate and destigmatized detection of recent cannabis use

Funded at Ricovr Healthcare INC. · NIH-10759597 · Data updated 2026-11-12

This study is testing a new, easy-to-use device called XALIVA® that can quickly and accurately measure THC levels in saliva, making it helpful for workplaces and public places to better understand cannabis use and promote safety.

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionRicovr Healthcare INC.
NIH-funded
Lab location1 site (Princeton, United States)
Project startJuly 1, 2024
Project endJune 30, 2025
Funding year2024
Award (this year)$295,606
NIH project number1R43DA059318-01
Project IDNIH-10759597 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who may be subject to cannabis use monitoring, such as those in workplaces or treatment programs for Cannabis Use Disorder.

Less likely to help

Patients who do not use cannabis or are not involved in environments where cannabis use monitoring is relevant may not benefit from this research.

What this research studies

This research aims to create a point-of-need device called XALIVA® that can accurately measure THC levels in saliva, helping to reduce the stigma associated with cannabis use. The device is designed to be user-friendly and requires no special training, making it suitable for various settings such as workplaces and public areas. By providing precise and sensitive detection of recent cannabis use, this device could improve monitoring processes and enhance public safety. The research will also explore innovative biosensor technology to ensure effective THC quantification.

Why it matters

Potential benefit: If successful, this research could lead to more accurate and stigma-free monitoring of cannabis use, benefiting individuals with Cannabis Use Disorder and improving public safety.

How similar studies have gone: Other research has shown promise in developing biosensor technologies for drug detection, suggesting that this approach could be effective.

Where this research is happening

  • Ricovr Healthcare INC.
    Princeton, United States
    Active

Researchers

  • Principal investigator: Seimetz, Joseph — Ricovr Healthcare INC.
  • Study coordinator: Seimetz, Joseph

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.